Investor Relations
Reporting Q3 2021
Evonik has published its quarterly report Q3 2021 on November 4, 2021. ... MORE
Investor Relations
How mRNA technology is shaping the future of medicine
Invitation to join industry roundtable on the future of mRNA technology ... MORE
Events
Division Spotlight Series
After the successful implementation of our new division structure in 2020, we took it a step further this year: We have hosted a "Division Spotlight Series" for our three growth divisions over the first half of 2021. ... MORE
Further Information
Company
Events & Presentations
Here you will find dates, information and presentations on our events. ... MORE
Company
Analysts' estimates
Evonik Industries AG is covered by German and international financial analysts, who provide their own research analyses and earnings estimates in respect of the company. ... MORE
Company
News & Reports
Here you can find "Investor Relations News" with the latest news from our company, plus our most recent interim reports, annual reports and corporate responsibility reports. ... MORE
Reporting 2022
-
March 3, 2022Quarterly Report Q4 2021
-
May 6, 2022Quarterly Report Q1 2022
-
August 3, 2022Quarterly Report Q2 2022
-
November 8, 2022Quarterly Report Q3 2022
Investor Relations
Nov 04, 2021
Evonik: 2021 earnings expected at top end of forecast range
Essen, Germany. After a strong third quarter, Evonik is making its earnings forecast for the current year more precise. ... MORE
Investor Relations
Oct 28, 2021
Evonik acquires sustainable botanicals pioneer Botanica as the next step towards leading the active cosmetic ingredients market
Essen, Germany. Evonik has signed a purchase agreement to acquire the Swiss plant extract producer Botanica, with closing expected in November. ... MORE
Investor Relations
Oct 01, 2021
Evonik to divest Lülsdorf site
Evonik intends to divest its Lülsdorf site in the medium term ... MORE
Investor Relations
Aug 26, 2021
Evonik successfully issues first green hybrid bond
Evonik Industries AG today successfully issued a first green hybrid bond with a nominal volume of €500 million. ... MORE
Investor Relations
Aug 05, 2021
Evonik grows strongly in the first half of the year and raises outlook for 2021
Evonik has raised its outlook for 2021 after posting strong earnings in the first half. ... MORE
Investor Relations
Jun 15, 2021
Evonik boosts its system solutions portfolio with the acquisition of the cosmetic delivery company Infinitec Activos
Essen, Germany. Evonik has signed a purchase agreement to acquire the privately owned technology-driven company Infinitec Activos, with closing expected by July. ... MORE
Further Information
Company
Financial data
Evonik is active in over 100 countries around the world. In fiscal 2018 more than 36,000 employees generated sales of €15 billion and an operating profit (adjusted EBITDA) of €2.6 billion. ... MORE
Company
Bonds & Rating
Evonik maintains a centralized approach to financing. Liabilities for credit and loans are fully guaranteed by Evonik Industries AG. ... MORE
Company
Key Figures Share
Here you find information about Evonik shares. ... MORE
Company
Contact & Service
You can find the contacts in the Investor Relations Department here. ... MORE
Company
Disclaimer
Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained. ... MORE
Company
Corporate Governance
As a globally active company, we have to comply with a wide range of statutory regulations and cultural standards. ... MORE
Investor Relations
Sustainable Investment (SRI)
We accept responsibility for our businesses, our employees, the environment and the society. ... MORE